TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: Nov 20, 2024, 4:00 PM
1.370
+0.030 (2.24%)
After-hours: Nov 20, 2024, 4:21 PM EST

Company Description

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States.

It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names.

The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.

TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TherapeuticsMD, Inc.
TherapeuticsMD logo
Country United States
Founded 2008
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1
CEO Marlan Walker

Contact Details

Address:
951 Yamato Road, Suite 220
Boca Raton, Florida 33431
United States
Phone 561 961 1900
Website therapeuticsmd.com

Stock Details

Ticker Symbol TXMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000025743
CUSIP Number 88338N206
ISIN Number US88338N2062
Employer ID 87-0233535
SIC Code 2834

Key Executives

Name Position
Marlan D. Walker J.D. Chief Executive Officer
Governor Thomas G. Thompson Executive Chairman
Joseph A. Ziegler Principal Financial and Accounting Officer
Douglas Steelman Vice President of Market Access

Latest SEC Filings

Date Type Title
Nov 12, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K Current Report
Oct 25, 2024 ARS Filing
Oct 25, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 25, 2024 DEF 14A Other definitive proxy statements
Sep 20, 2024 8-K Current Report
Aug 12, 2024 10-Q Quarterly Report
Aug 12, 2024 8-K Current Report
Jun 14, 2024 AW Amendment Withdrawal Request